Treatment of Testosterone deficiency in men with Sleep Apnoea Syndrome utilising Nebido therapy.

Trial Profile

Treatment of Testosterone deficiency in men with Sleep Apnoea Syndrome utilising Nebido therapy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Oct 2013

At a glance

  • Drugs Testosterone undecanoate (Primary)
  • Indications Hypogonadism; Sleep apnoea syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top